The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Antiretroviral Therapy
(Part XXV)

Clinical Implications of Resistance To Antiretroviral Drugs

November 21, 1997

VA Medical Center, San Francisco

Further Reading

Carpenter CJ et al. Antiretroviral therapy for HIV infection in 1996. Recommendation of an international panel, International AIDS Society-USA. JAMA. 1996;276:146-54.

Carpenter CJ et al. Antiretroviral therapy for HIV infection in 1997: Updated recommendations of an international panel. JAMA. 1997;277:1962-9.

Ho DD et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 1995;373:123-6.

Mellors JW et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 1996;272:1167-70.

Perelson AS et al. HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time. Science. 1996;271:1582-6.

Richman DD. HIV therapeutics. Science. 1996;272:1886-8.

Shirasaka T et al. Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides. Proc Natl Acad USA. 1995;92:2398-402.

Vella S and Floridia M. Combination antiretroviral therapy. Bailliere's Clinical Infectious Diseases. 1996;3(1):79-101.

Wei X et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373.117.22.0


  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary